Annual SGA
$49.08 M
-$1.31 M-2.61%
December 31, 2024
Summary
- As of March 13, 2025, ITOS annual SGA is $49.08 million, with the most recent change of -$1.31 million (-2.61%) on December 31, 2024.
- During the last 3 years, ITOS annual SGA has risen by +$8.58 million (+21.17%).
- ITOS annual SGA is now -2.61% below its all-time high of $50.40 million, reached on December 31, 2023.
Performance
ITOS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$11.81 M
-$303.00 K-2.50%
December 31, 2024
Summary
- As of March 13, 2025, ITOS quarterly SGA is $11.81 million, with the most recent change of -$303.00 thousand (-2.50%) on December 31, 2024.
- Over the past year, ITOS quarterly SGA has dropped by -$303.00 thousand (-2.50%).
- ITOS quarterly SGA is now -21.80% below its all-time high of $15.10 million, reached on June 30, 2021.
Performance
ITOS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$189.86 M
-$134.41 M-41.45%
December 31, 2024
Summary
- As of March 13, 2025, ITOS TTM SGA is $189.86 million, with the most recent change of -$134.41 million (-41.45%) on December 31, 2024.
- Over the past year, ITOS TTM SGA has increased by +$140.22 million (+282.46%).
- ITOS TTM SGA is now -78.71% below its all-time high of $891.65 million.
Performance
ITOS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ITOS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.6% | -2.5% | +282.5% |
| 3 y3 years | +21.2% | +23.0% | +368.7% |
| 5 y5 years | +455.4% | +418.9% | +2048.4% |
ITOS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.6% | +21.2% | -12.1% | +23.0% | -78.7% | +280.9% |
| 5 y | 5-year | -2.6% | +455.4% | -21.8% | +418.9% | -78.7% | +156.8% |
| alltime | all time | -2.6% | +1038.2% | -21.8% | +567.5% | -78.7% | +156.8% |
ITeos Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $49.08 M(-2.6%) | $11.81 M(-2.5%) | $49.08 M(-1.1%) |
| Sep 2024 | - | $12.11 M(-2.8%) | $49.64 M(-1.1%) |
| Jun 2024 | - | $12.46 M(-1.9%) | $50.17 M(-1.9%) |
| Mar 2024 | - | $12.70 M(+2.7%) | $51.15 M(+1.5%) |
| Dec 2023 | $50.40 M(+14.7%) | $12.37 M(-2.2%) | $50.37 M(+2.6%) |
| Sep 2023 | - | $12.64 M(-5.9%) | $49.10 M(+4.0%) |
| Jun 2023 | - | $13.44 M(+12.6%) | $47.22 M(+4.3%) |
| Mar 2023 | - | $11.93 M(+7.4%) | $45.26 M(+3.0%) |
| Dec 2022 | $43.95 M(+8.5%) | $11.10 M(+3.2%) | $43.95 M(+3.5%) |
| Sep 2022 | - | $10.76 M(-6.2%) | $42.44 M(+4.9%) |
| Jun 2022 | - | $11.47 M(+8.1%) | $40.45 M(-8.2%) |
| Mar 2022 | - | $10.62 M(+10.6%) | $44.08 M(+8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $40.51 M(+164.0%) | $9.60 M(+9.6%) | $40.51 M(+10.6%) |
| Sep 2021 | - | $8.76 M(-42.0%) | $36.64 M(+12.1%) |
| Jun 2021 | - | $15.10 M(+114.3%) | $32.67 M(+63.6%) |
| Mar 2021 | - | $7.05 M(+23.0%) | $19.97 M(+30.2%) |
| Dec 2020 | $15.34 M(+73.6%) | $5.73 M(+19.4%) | $15.34 M(+29.0%) |
| Sep 2020 | - | $4.80 M(+100.5%) | $11.89 M(+21.5%) |
| Jun 2020 | - | $2.39 M(-1.0%) | $9.79 M(+3.2%) |
| Mar 2020 | - | $2.42 M(+6.2%) | $9.49 M(+7.3%) |
| Dec 2019 | $8.84 M(+104.9%) | $2.28 M(-15.7%) | $8.84 M(+34.7%) |
| Sep 2019 | - | $2.70 M(+29.0%) | $6.56 M(+69.9%) |
| Jun 2019 | - | $2.09 M(+18.3%) | $3.86 M(+118.3%) |
| Mar 2019 | - | $1.77 M | $1.77 M |
| Dec 2018 | $4.31 M | - | - |
FAQ
- What is iTeos Therapeutics annual SGA?
- What is the all time high annual SGA for iTeos Therapeutics?
- What is iTeos Therapeutics annual SGA year-on-year change?
- What is iTeos Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly SGA year-on-year change?
- What is iTeos Therapeutics TTM SGA?
- What is the all time high TTM SGA for iTeos Therapeutics?
- What is iTeos Therapeutics TTM SGA year-on-year change?
What is iTeos Therapeutics annual SGA?
The current annual SGA of ITOS is $49.08 M
What is the all time high annual SGA for iTeos Therapeutics?
iTeos Therapeutics all-time high annual SGA is $50.40 M
What is iTeos Therapeutics annual SGA year-on-year change?
Over the past year, ITOS annual SGA has changed by -$1.31 M (-2.61%)
What is iTeos Therapeutics quarterly SGA?
The current quarterly SGA of ITOS is $11.81 M
What is the all time high quarterly SGA for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly SGA is $15.10 M
What is iTeos Therapeutics quarterly SGA year-on-year change?
Over the past year, ITOS quarterly SGA has changed by -$303.00 K (-2.50%)
What is iTeos Therapeutics TTM SGA?
The current TTM SGA of ITOS is $189.86 M
What is the all time high TTM SGA for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM SGA is $891.65 M
What is iTeos Therapeutics TTM SGA year-on-year change?
Over the past year, ITOS TTM SGA has changed by +$140.22 M (+282.46%)